Difference between revisions of "Team:ETH Zurich/Achievements"
Line 41: | Line 41: | ||
<li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We designed 8 synthetic <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">LldR dependent promoters</a> and characterized them. Additionally, the influence of the lacate importer LldP was characterized.</li> | <li><img src="https://static.igem.org/mediawiki/2015/5/51/ETH15_Bronze_medal.png" align="right" width="1.8%">We designed 8 synthetic <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">LldR dependent promoters</a> and characterized them. Additionally, the influence of the lacate importer LldP was characterized.</li> | ||
− | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a | + | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a limited amount of information present in the literature.</li> |
<li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li> | <li><img src="https://static.igem.org/mediawiki/2015/9/9b/ETH15_Gold_medal.png" align="right" width="1.8%">We documented and submitted two new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with 14 parts.</li> | ||
− | <li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for | + | <li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for future application of our MicroBeacon <i>E. coli</i>.</li> |
<li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li> | <li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li> | ||
Line 54: | Line 54: | ||
<h3>Modeling Achievements</h3> | <h3>Modeling Achievements</h3> | ||
− | <ul><li> | + | <ul> |
+ | |||
+ | <li>We separately modeled two different signals of our cancer detection system, the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">Lactate Module</a> and the <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module"> AHL Module</a>.</li> | ||
+ | |||
+ | <li> We defined and estimated <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Parameters">all relevant parameters for our models</a>.</li> | ||
+ | |||
+ | <li>We integrated the two modules into a <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Single-cell_Model">Combined Compartment Model</a> to simulate a logical AND gate.</li> | ||
+ | |||
+ | <li>To account for the diffusion and degradation of signaling molecules under real-world conditions we designed various <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Reaction-diffusion">Reaction-diffusion Models</a>.</li> | ||
+ | |||
+ | <li>We optimized our model by <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Experiments_Modelintegrating">integrating experimental data</a> gathered by the characterization of our LldR promoter constructs.</li> | ||
+ | |||
+ | <li>We showed that the successful detection of cancer cells with our system <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling#Conclusions">is feasible in principle</a>.</li> | ||
+ | |||
+ | </ul> | ||
<p></p> | <p></p> |
Revision as of 09:02, 18 September 2015
- Project
- Modeling
- Lab
- Human
Practices - Parts
- About Us
Achievements
We are proud to announce that we achieved the following goals
General Achievements
- We completed the Judging Form
- We created a description of our project in time and documented each aspect of the project on this page.
- Documented 20 parts taken from the Registry of Standard Biological Parts.
Experimental Achievements
- We designed a novel system for detection of circulating tumour cells in blood samples using genetically modified bacteria.
- We designed a genetic circuit that integrates two different cancer specific signals (lactate and AHL)in an AND gate.
- We implemented a method to do single cell analysis of cancer cells by expressing Annexin V in the E. coli outer membrane, which enables them to selectively bind to apoptotic cancer cells.
- We designed 8 synthetic LldR dependent promoters and characterized them. Additionally, the influence of the lacate importer LldP was characterized.
- We characterized parts of the natural E. coli lldPRD-operon, on which there is only a limited amount of information present in the literature.
- We documented and submitted two new basic parts to the iGEM parts registry and created a part collection with 14 parts.
- We designed a chip for future application of our MicroBeacon E. coli.
- We participated in the interlab study.
- Our experiments complied with the safety instructions at the Department of Biosystems Science and Engineering D-BSSE in Basel where our lab is situated.
Modeling Achievements
- We separately modeled two different signals of our cancer detection system, the Lactate Module and the AHL Module.
- We defined and estimated all relevant parameters for our models.
- We integrated the two modules into a Combined Compartment Model to simulate a logical AND gate.
- To account for the diffusion and degradation of signaling molecules under real-world conditions we designed various Reaction-diffusion Models.
- We optimized our model by integrating experimental data gathered by the characterization of our LldR promoter constructs.
- We showed that the successful detection of cancer cells with our system is feasible in principle.
Human Practices Achievements
- We went to two different schools, thaught the children about what DNA is, performed experiments with them and published an article about it in the local newspaper.
- We told the ETH-student magacine polykum about iGEM and gave an interview.
- We collaborated with the team from Stockholm by testing some of their constructs.
- We contributed to the Newsletters from Amoys team, met with the Darmstadt team, helped with a survey from EPFL and provided Colombias team with protocols and advice when their transformations did not work.
- We interviewed many different experts from various fields, such as medical doctors, somebody from the ethics commission, the founder of a start-up or an expert in patents law and integrated the advice and ideas we got from them into the design.